# ERZOFRI
> **NDA216352** · New Drug Application · Sponsor: LUYE INNOMIND PHARMA · Approved 2024-07-26
## Drug
- **FDA Application Number:** NDA216352
- **Application type:** New Drug Application
- **Brand name:** ERZOFRI
- **Generic name:** PALIPERIDONE PALMITATE
- **Active ingredients:** PALIPERIDONE PALMITATE
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** LUYE INNOMIND PHARMA
- **Manufacturer:** Shandong Luye Pharmaceutical Co., Ltd.
- **First approval:** 2024-07-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216352)
---
*MORVS · CC0 1.0*